Citadel Advisors’s ProShares S&P 500 ex-Health Care ETF SPXV Stock Holding History
Bought
Maintained
Sold
Other funds holding SPXV
Citadel Advisors's SPXV Position: Q2 2023 in Review
Citadel Advisors sold out of ProShares S&P 500 ex-Health Care ETF (SPXV) in Q2 2023, closing a stake of 14,620 shares — an estimated $624K sold.
Citadel Advisors first reported a position in SPXV in Q2 2021 and held it in 8 quarters. The position peaked at $624K in Q1 2023. 10 funds tracked by Wall St. Rank hold SPXV as of Q2 2023.
- Citadel Advisors reported no remaining ProShares S&P 500 ex-Health Care ETF position as of Q2 2023 after selling out during the quarter.
- Citadel Advisors sold 14,620 ProShares S&P 500 ex-Health Care ETF shares in Q2 2023, an estimated $624K.
- Citadel Advisors first reported a position in ProShares S&P 500 ex-Health Care ETF in Q2 2021 and held it in 8 quarters.
- Citadel Advisors's ProShares S&P 500 ex-Health Care ETF position peaked at $624K in Q1 2023.
- 10 funds tracked by Wall St. Rank held ProShares S&P 500 ex-Health Care ETF as of Q2 2023.
Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.